Scaffold-Constrained Molecular Generation
Abstract
One of the major applications of generative models for drug discovery targets the leadoptimization phase. During the optimization of a lead series, it is common to have scaffold constraints imposed on the structure of the molecules designed. Without enforcing such constraints, the probability of generating molecules with the required scaffold is extremely low and hinders the practicality of generative models for de-novo drug design. To tackle this issue, we introduce a new algorithm to perform scaffold-constrained in-silico molecular design. We build on the well-known SMILES-based Recurrent Neural Network (RNN) generative model, with a modified sampling procedure to achieve scaffold-constrained generation. We directly benefit from the associated reinforcement learning methods, allowing to 1 arXiv:2009.07778v3 [q-bio.QM] 5 Oct 2020 design molecules optimized for different properties while exploring only the relevant chemical space. We showcase the method's ability to perform scaffold-constrained generation on various tasks: designing novel molecules around scaffolds extracted from SureChEMBL chemical series, generating novel active molecules on the Dopamine Receptor D2 (DRD2) target, and finally, designing predicted actives on the MMP-12 series, an industrial lead-optimization project.
Domains
Chemical Sciences
Fichier principal
Langevin et al. - 2020 - Scaffold-Constrained Molecular Generation.pdf (1.28 Mo)
Télécharger le fichier
Origin | Files produced by the author(s) |
---|